The correlation between MCT2 expression and poor prognosis in breast cancer was further strengthened when combined with either high expression of IL-1β or LCN2 (cut-off value of −ΔCt: −7.34 for IL-1β and −7.42 for LCN2, respectively) (Fig. 7e). Here, SLC16A7 is linked to breast cancer.